The Fenland Study is investigating the interaction between environmental and genetic factors in determining obesity, type 2 diabetes, and related metabolic disorders. These conditions are a considerable public health concern, but their causes and factors that predict who will be affected by them are not completely understood.
The Fenland Study is unique in the level of detail it collects about the health and lifestyle of participants, and the objective measurement techniques used in the screening.
Phase 1 of the Fenland study was completed in 2015, Phase 2 in 2020, and Phase 3 in 2025.
Novo Nordisk Inter-SUSTAIN funding call
The Fenland Study has recently been shortlisted by the Novo Nordisk Foundation to take part in their Inter-SUSTAIN call.
There is now an opportunity for researchers to submit proposed research projects to compete for funding as the second part of this call. If a research project is successful then both the researcher and the study database will receive funding, helping to not only support the research project but also support improving and maintaining the study database.
More information can be found on the Novo Nordisk Foundation website.
If you are a researcher considering submitting a data request, we would encourage you to take a look at the Novo Nordisk Foundation website and consider submitting a project proposal before the closing date of 10th February 2026.
